| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:09:42 -0700 |
| HMDB ID |
HMDB00985 |
| Secondary Accession Numbers |
|
| Metabolite Identification |
| Common Name |
Dihydrolipoamide |
| Description |
Dihydrolipoamide is an intermediate in glycolysis/gluconeogenesis, citrate cycle (TCA cycle), alanine, aspartate and pyruvate metabolism, and valine, leucine and isoleucine degradation (KEGG ID C00579). It is converted to lipoamide via the enzyme dihydrolipoamide dehydrogenase [EC:1.8.1.4]. Dihydrolipoamide is also a substrate of enzyme Acyltransferases [EC 2.3.1.-]. (KEGG). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 6,8-Bis-sulfanyloctanamide
- 6,8-Dimercapto-Octanamide
- 6,8-Dimercaptooctanamide
- 6,8-Disulfanyloctanamide
- Dihydrolipoamide
- Dihydrothioctamide
|
| Chemical Formula |
C8H17NOS2 |
| Average Molecular Weight |
207.357 |
| Monoisotopic Molecular Weight |
207.075155551 |
| IUPAC Name |
6,8-disulfanyloctanimidic acid |
| Traditional IUPAC Name |
6,8-disulfanyloctanimidic acid |
| CAS Registry Number |
3884-47-7 |
| SMILES |
OC(=N)CCCCC(S)CCS |
| InChI Identifier |
InChI=1S/C8H17NOS2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H2,9,10) |
| InChI Key |
VLYUGYAKYZETRF-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aliphatic Acyclic Compounds |
| Class |
Thiols |
| Sub Class |
Alkylthiols |
| Other Descriptors |
- Thiols
- a small molecule(Cyc)
- dithiol(ChEBI)
- monocarboxylic acid amide(ChEBI)
|
| Substituents |
|
| Direct Parent |
Alkylthiols |
| Ontology |
| Status |
Expected and Not Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
Not Available
|
| Tissue Location |
Not Available
|
| Pathways |
| Name |
SMPDB Link |
KEGG Link |
| Valine, Leucine and Isoleucine Degradation |
SMP00032
|
map00280
|
|
| Normal Concentrations |
|
Not Available |
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022352 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
643  |
| KEGG Compound ID |
C00579  |
| BioCyc ID |
DIHYDROLIPOAMIDE  |
| BiGG ID |
35406  |
| Wikipedia Link |
Dihydrolipoamide  |
| NuGOwiki Link |
HMDB00985  |
| Metagene Link |
HMDB00985  |
| METLIN ID |
5920  |
| PubChem Compound |
663  |
| PDB ID |
Not Available |
| ChEBI ID |
17694  |
| References |
| Synthesis Reference |
Weitzman, P. D. J.; Hewson, Janet K.; Parker, M. G. Preparation of dihydrolipoamide by electrolytic reduction. FEBS Letters (1974), 43(1), 101-3. |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Brautigam CA, Chuang JL, Tomchick DR, Machius M, Chuang DT: Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations. J Mol Biol. 2005 Jul 15;350(3):543-52.
Pubmed: 15946682
- Kim H: Asparagine-473 residue is important to the efficient function of human dihydrolipoamide dehydrogenase. J Biochem Mol Biol. 2005 Mar 31;38(2):248-52.
Pubmed: 15826505
- McMillan PJ, Stimmler LM, Foth BJ, McFadden GI, Muller S: The human malaria parasite Plasmodium falciparum possesses two distinct dihydrolipoamide dehydrogenases. Mol Microbiol. 2005 Jan;55(1):27-38.
Pubmed: 15612914
- Li XJ, Grunwald D, Mathieu J, Morel F, Stasia MJ: Crucial role of two potential cytosolic regions of Nox2, 191TSSTKTIRRS200 and 484DESQANHFAVHHDEEKD500, on NADPH oxidase activation. J Biol Chem. 2005 Apr 15;280(15):14962-73. Epub 2005 Jan 31.
Pubmed: 15684431
- Deres P, Halmosi R, Toth A, Kovacs K, Palfi A, Habon T, Czopf L, Kalai T, Hideg K, Sumegi B, Toth K: Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound. J Cardiovasc Pharmacol. 2005 Jan;45(1):36-43.
Pubmed: 15613977
|